Intratumoral B cells as predictive biomarkers for response to immune check point blockade in patients with recurrent ovarian cancer

被引：0
|
作者：
Varghese, Aaron [1 ]
Reddy, Shanmuga [1 ]
Cortes, Eduardo [1 ]
Liu, Song [1 ]
Attwood, Kristopher [1 ]
Odunsi, Kunle [1 ]
Zsiros, Emese [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
361
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [1] The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer
    Xu, Yufei
    Zuo, Fengli
    Wang, Huiling
    Jing, Jing
    He, Xiujing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Inhibition of nucleophosmin/B23 sensitizes ovarian cancer cells to immune check-point blockade via PD-L1 in ovarian cancer
    Tsai, Chia-Lung
    Tang, Yun-Hsin
    Yang, Lan-Yan
    Chao, Angel
    Wang, Chin-Jung
    Lin, Chiao-Yun
    Lai, Chyong-Huey
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (10) : 1045 - 1056
  • [3] Immune biomarkers predictive of survival in epithelial ovarian cancer
    Simons, E.
    Kiet, T.
    Amanam, I.
    Ho, M.
    Fuh, J.
    Fuh, K.
    Kapp, D.
    Odunsi, K.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S45 - S46
  • [4] Orchestrating immune check-point blockade for cancer immunotherapy in combinations
    Luis Perez-Gracia, Jose
    Labiano, Sara
    Rodriguez-Ruiz, Maria E.
    Sanmamed, Miguel F.
    Melero, Ignacio
    CURRENT OPINION IN IMMUNOLOGY, 2014, 27 : 89 - 97
  • [5] PREDICTIVE SOLUBLE BIOMARKERS OF IMMUNE RESPONSE TO CHECKPOINT BLOCKADE IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Raza, Afsheen
    Mohsen, Reyad
    Kanbour, Aladdin
    Gul, Abdul Rehman Zar
    Philip, Anite
    Vijayakumar, Suma
    Hydrose, Shereena
    Merhi, Maysaloun
    Inchakalody, Varghese
    Uddin, Shahab
    Al Homsi, Mohammed Ussama
    Dermime, Said
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A19 - A19
  • [6] Biomarkers of response to immune checkpoint blockade in cancer treatment
    Fujii, Takeo
    Naing, Aung
    Rolfo, Christian
    Hajjar, Joud
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 130 : 108 - 120
  • [7] Targeted therapy of ovarian cancer including immune check point inhibitor
    Kim, Jin Young
    Cho, Chi Heum
    Song, Hong Suk
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (05): : 798 - 804
  • [8] The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
    Chen, Hao
    Yang, Meng
    Wang, Qinghua
    Song, Fengju
    Li, Xiangchun
    Chen, Kexin
    ONCOIMMUNOLOGY, 2019, 8 (08):
  • [9] GOG-3003: IDENTIFYING BIOMARKERS PREDICTIVE OF IMMUNE AND CLINICAL RESPONSE IN A PHASE 2 RCT OF CHEMO-IMMUNOTHERAPY IN RECURRENT OVARIAN CANCER
    Coukos, G.
    Brady, M. F.
    Lankes, H. A.
    Aghajanian, C.
    Gottardo, R.
    Swisher, E. M.
    Kandalaft, L.
    Foukas, P. G.
    Rizack, T.
    Leach, J.
    Salani, R.
    Higgins, R.
    Hanjani, P.
    Morgan, M.
    Edwards, R.
    Bryan, J. K.
    Manjarrez, K. L.
    Mannel, R. S.
    Hershberg, R. M.
    Monk, B. J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 26 - 27
  • [10] Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?
    Gascon, Marta
    Isla, Dolores
    Cruellas, Mara
    Galvez, Eva M.
    Lastra, Rodrigo
    Ocariz, Maitane
    Ramon Pano, Jose
    Ramirez, Ariel
    Sesma, Andrea
    Torres-Ramon, Irene
    Yubero, Alfonso
    Pardo, Julian
    Martinez-Lostao, Luis
    CELLS, 2020, 9 (06) : 1 - 16
12345